Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evolus Inc (NQ: EOLS ) 15.95 -0.40 (-2.45%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Evolus Inc < Previous 1 2 3 4 5 6 Next > Evolus to Participate in November Investor Conferences November 01, 2023 From Evolus Via Business Wire Evolus to Report Third Quarter 2023 Results October 25, 2023 From Evolus Via Business Wire Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting October 25, 2023 From Evolus Via Business Wire 7 Must-Own Small-Cap Stocks That Could Outperform the Market October 08, 2023 If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you. Via InvestorPlace Earnings Preview: Evolus August 01, 2023 Via Benzinga 5 Analysts Have This to Say About Evolus July 28, 2023 Via Benzinga Evolus Inc. (NASDAQ: EOLS) Highlighted for Surprising Price Action July 27, 2023 Via Investor Brand Network Why Shares of Evolus Are Jumping Thursday July 27, 2023 The stock climbed on record second-quarter revenue and a raise in full-year guidance. Via The Motley Fool Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 29, 2023 From Evolus Via Business Wire 7 Small-Cap Stocks Analysts Predict Will Double in 2024 September 13, 2023 While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors. Via InvestorPlace Evolus to Participate in September Conferences August 29, 2023 From Evolus Via Business Wire Evolus Announces Inducement Grants for New Chief Marketing Officer August 23, 2023 From Evolus Via Business Wire Expert Ratings for Evolus May 26, 2023 Via Benzinga This Analyst Likes Evolus As 'Top Play In Aesthetics' May 10, 2023 Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S. Via Benzinga Expert Ratings for Evolus May 10, 2023 Via Benzinga Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer August 21, 2023 From Evolus Via Business Wire Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying August 16, 2023 Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades. Via Benzinga Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline August 08, 2023 Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the... Via Newsfile Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers August 08, 2023 From Evolus Via Business Wire Evolus Reports Second Quarter 2023 Results and Provides Business Update August 02, 2023 From Evolus Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session July 27, 2023 Via Benzinga Comcast, STMicroelectronics, Lam Research, Meta Platforms And Other Big Stocks Moving Higher On Thursday July 27, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 27, 2023 Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. Via Benzinga Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue July 27, 2023 From Evolus Via Business Wire Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference July 26, 2023 From Evolus, Inc. Via Business Wire Evolus to Report Second Quarter 2023 Results and Provide Business Update July 19, 2023 From Evolus Via Business Wire Twitter Faces Threats From AI and Threads July 15, 2023 AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience. Via The Motley Fool Evolus Launches Nuceiva® (botulinum toxin type A) in Italy June 29, 2023 From Evolus Via Business Wire Evolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ® June 22, 2023 From Evolus Via Business Wire Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program June 08, 2023 From Evolus Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.